Priced out of the NBA and NFL, investors are asking bankers about opportunities to buy minority stakes in teams with lower valuations.

MAHA advocates said the language that was stripped could have provided liability protection for Bayer in lawsuits involving its Roundup weedkiller.

The House on Thursday passed a Department of Homeland Security funding bill that the Senate had approved more than a month ago.

Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.

Here are the stocks making headlines in midday trading.

Blue Owl said it's made 10 times its investment in SpaceX, which is headed for a record IPO later this year.

Despite a recent minor bullish divergence, momentum remains broadly weak. This reinforces a broken primary trend.

"The Real Eisman Playbook" podcast host and former Neuberger Berman senior portfolio manager said the market environment looks strikingly similar to last year.

The U.S. and Iran are locked in a standoff that will only break when one side decides it can no longer tolerate the pain. Who will move is unclear.

Exchanges are leaning into products like event contracts and futures as a way to stabilize revenue that otherwise swings with crypto prices.